Skip to main navigation menu Skip to main content Skip to site footer

Alveolar hemorrhage due to Leptospirosis in times of Covid 19. About a Case.

Hemorragia alveolar por leptospirosis en tiempos de COVID-19. Acerca de un caso




Section
Reporte de caso

How to Cite
Alveolar hemorrhage due to Leptospirosis in times of Covid 19. About a Case.
rev. colomb. neumol. [Internet]. 2022 Nov. 30 [cited 2024 Dec. 4];34(2):86-92. Disponible en: https://doi.org/10.30789/rcneumologia.v34.n2.2022.595

Dimensions
PlumX
license

Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo  los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.

Suyapa Sosa Ferrari
    Guillermo Zaldívar Aparicio

      Suyapa Sosa Ferrari ,

      Especialista en Neumología. Jefe del Servicio de Neumología y Coordinadora del Postgrado de Neumología. Instituto Nacional Cardiopulmonar. Tegucigalpa, Honduras.


      Leptospirosis is a prevalent and generalized zoonotic disease, for which there are no reliable figures of world incidence. It is an underreported disease that can generate a significant number of morbidity and mortality. The incidence of pulmonary involvement in leptospirosis varies from 20% to 70%, and alveolar hemorrhage that presents with dyspnea and hemoptysis is the main pulmonary manifestation in leptospirosis, generating mortality that can be greater than 50% if it is not detected and drive on time. We present the case of a 30-year-old patient with respiratory symptoms and fever that suggested Covid 19 due to radiological images and due to the pandemic, with a history of being a bottle collector, who due to the sudden drop in hemoglobin without a precise site of bleeding was thought to be alveolar hemorrhage, serology was performed for leptospira, which was positive, and he could be treated in a timely manner. In conclusion, a good questioning about daily activities together with good clinical judgment and interpretation of laboratory tests should make us suspect alveolar hemorrhage due to leptospirosis.


      Article visits 517 | PDF visits 409


      Downloads

      Download data is not yet available.
      1. Costa F, Hagan JE, Calcagno J, Kane M, Torgerson P, Martinez-Silveira MS, et al. Global Morbidity and Mortality of Leptospirosis: A Systematic Review. PLoS Negl Trop Dis. 2015;9(9):1-19. doi: 10.1371/journal.pntd.0003898
      2. Torgerson PR, Hagan JE, Costa F, Calcagno J, Kane M, Martinez-Silveira MS, et al. Global Burden of Leptospirosis: Estimated in Terms of Disability Adjusted Life Years. PLoS Negl Trop Dis. 2015;9(10):1-14. doi: 10.1371/journal.pntd.0004122
      3. Dolhnikoff M, Mauad T, Bethlem EP, Carvalho CRR. Pathology and pathophysiology of pulmonary manifestations in leptospirosis. Braz J Infect Dis. 2007;11:142-8. doi: 10.1590/s1413-86702007000100029
      4. Lau CL, Smythe LD, Craig SB, Weinstein P. Climate change, flooding, urbanisation and leptospirosis: fuelling the fire? Transactions of the Royal Society of Tropical Medicine and Hygiene. 2010; 104: 631–638 doi: 10.1016/j.trstmh.2010.07.002
      5. Haake, D.A.; Levett, P.N. Leptospirosis in humans. Curr. Top. Microbiol. Immunol. 2015, 387, 65–97. doi: 10.1007/978-3-662-45059-8_5
      6. Céspedes Z M. Leptospirosis: Enfermedad Zoonótica Emergente. Revista Peruana de Medicina Experimental y Salud Publica. octubre de 2005;22(4):290-307. ISSN 1726-4634
      7. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis. 2003;3:757-71. doi: 10.1016/s1473-3099(03)00830-2
      8. OMS. Leptospirosis humana: guía para el diagnóstico, vigilancia y control; traducción del Centro Panamericano de Fiebre Aftosa. Rio de Janeiro: Centro Panamericano de Fiebre Aftosa; 2008. ISSN 0101-6970
      9. Von Ranke FM, Zanetti G, Hochhegger B, Marchiori E. Infectious diseases causing diffuse alveolar hemorrhage in immunocompetent patients: a state-of-the-art review. Lung. febrero de 2013;191(1):9-18. doi: 10.1007/s00408-012-9431-7
      10. Helmerhorst HJF, van Tol EN, Tuinman PR, de Vries PJ, Hartskeerl RA, Grobusch MP, et al. Severe pulmonary manifestation of leptospirosis. The Netherlands Journal of Medicine, 01 Jun 2012;70(5):215-221 PMID: 22744922
      11. Montero-Tinnirello J, de la Fuente-Aguado J, Ochoa-Diez M, Cabadas-Avión R. Hemorragia pulmonar por leptospirosis. Medicina Intensiva. 2012;36(1):58-9. doi: 10.1016/j.medin.2011.04.002
      12. Divate S.A., Chaturvedi R., Jadhav N.N., Vaideeswar P. Leptospirosis associated with diffuse alveolar hemorrhage. J Postgrad Med. 2002;48:131-2. PMID: 12215699
      13. Gulati S, Gulati A. Pulmonary manifestations of leptospirosis. Lung India. 2012;29(4):347-53. doi: 10.4103/0970-2113.102822
      14. Escuissato DL, Warszawiak D, Marchiori E. Differential diagnosis of diffuse alveolar haemorrhage in immunocompromised patients. Curr Opin Infect Dis. 2015;28(4):337-42. doi: 10.1097/QCO.0000000000000181
      15. Ludwig B, Zotzmann V, Bode C, Staudacher DL, Zschiedrich S. Lethal pulmonary hemorrhage syndrome due to Leptospira infection transmitted by pet rat. IDCases. 2017;8:84-6. doi: 10.1016/j.idcr.2017.04.016
      Sistema OJS 3.4.0.7 - Metabiblioteca |